MULTIPLE MYELOMA: A TEXTBOOK FOR NURSES
Novel chemotherapeutic agents have revolutionized the treatment approaches for patients with multiple myeloma (MM) in the past decade. In contrast with conventional chemotherapies used in the 1960s through the late 1990s, novel agents offer improved clinical outcomes and better quality of life for patients with MM. However, along with the advent of novel agents in 2000s came new, not-so-well-described side effects and clinical challenges from the lack of evidence-based nursing interventions that abrogate untoward effects from chemotherapies.
This book features a comprehensive review of nursing care of patients with MM in the era of novel agents. This is the first book on MM written by nurses, fornurses. Sections centered on nursing assessment, novel therapies, patient education, nursing management of side effects, survivorship, and nursing research in the context of MM provide comprehensive materials that are relevant to day-to-day nursing practice.
The contributors of this book are nurses who work in the top myeloma centers in the United States. These nursing experts work unremittingly to advance the art and science of myeloma care and endlessly dedicate their time and effort to disseminate important therapeutic breakthroughs to their nursing colleagues.
Despite the huge time commitment and rigorous timeline, each contributor has successfully completed and delivered excellent manuscripts while actively providing clinical care to patients with MM. Without the hard work and professionalism of all contributors, this book would not be a reality.
Lastly, patients who participated in clinical trials that led to the U.S. Food and Drug Administration approval of novel agents have left a lifelong legacy—better treatment options for patients with MM. This book is enriched by the insightful views and opinions shared by patients with MM to their oncology nurses.